Human Medicines
This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
Added in June 2025
20 June
NEW - 20-21 May CMDh minutes
16 June
NEW - 17-19…
modified 20/06/2025
Meeting 17-19 June 2025: AgendaMeeting 20-21 May 2025: Agenda - MinutesMeeting…
modified 20/06/2025
Questions and answers
A question-and-answer document is available for marketing…
modified 28/05/2025
Information on nitrosamines for marketing authorisation holders
modified 28/05/2025
European Medicines Regulatory Network approach for the implementation of…
added 28/05/2025
For additional specific information related to nationally authorised products…
added 28/05/2025
Questions and answers
A question-and-answer document is available for marketing…
added 28/05/2025
Information on nitrosamines for marketing authorisation holders
added 28/05/2025
National information on MAH transfers (May 2025)
modified 28/05/2025
Bilaxten and associated names (bilastine)End of procedure: 03/02/2025Date of…
modified 28/05/2025